Pimecrolimus, a topical calcineurin inhibitor used in the treatment of atopic eczema

Author： Prucha Hanna   Schnopp Christina   Akdis Cezmi   Lauener Roger   Wollenberg Andreas   Ring Johannes   Traidl-Hoffmann Claudia  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.9, Iss.11, 2013-11, pp. : 1507-1516

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Topical Calcineurin Inhibitors, Pimecrolimus and Tacrolimus

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 6, Iss. 3, 2007-01 ,pp. : 237-243

Bentham Science Publishers

Access to resources Recommend Favorite

Percutaneous absorption of drugs used in atopic eczema: pimecrolimus permeates less through skin than corticosteroids and tacrolimus

By Billich A.   Aschauer H.   Aszodi A.   Stuetz A.  

International Journal of Pharmaceutics, Vol. 269, Iss. 1, 2004-01 ,pp. : 29-35

Elsevier

Access to resources Recommend Favorite

Topical use of corticosteroids and calcineurin inhibitors is the key to effective treatment of atopic dermatitis

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 25, Iss. 3, 2009-03 ,pp. : 10-13

Adis International

Access to resources Recommend Favorite

Role of Topical Calcineurin Inhibitors on Atopic Dermatitis of Children

By  

Current Medicinal Chemistry, Vol. 14, Iss. 14, 2007-06 ,pp. : 1579-1591

Bentham Science Publishers

Access to resources Recommend Favorite

Topical Pimecrolimus: A Review of its Use in the Management of Pediatric Atopic Dermatitis

By Yang Lily P.H.   Curran Monique P.  

Pediatric Drugs, Vol. 11, Iss. 6, 2009-12 ,pp. : 407-426

Adis International

Access to resources Recommend Favorite